Overview
Regan Duffy is an Oncologist in Portland, Oregon. Dr. Duffy is highly rated in 9 conditions, according to our data. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Duffy is currently accepting new patients.
Her clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
OHSU Hospital
Brian Druker is an Oncologist in Portland, Oregon. Dr. Druker is highly rated in 8 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), and Philadelphia-Negative Chronic Myeloid Leukemia.
Brendan Curti is an Oncologist in Portland, Oregon. Dr. Curti is highly rated in 14 conditions, according to our data. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Chromophobe Renal Cell Carcinoma.
Rachel Sanborn is an Oncologist in Portland, Oregon. Dr. Sanborn is highly rated in 12 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Bone Marrow Aspiration. Dr. Sanborn is currently accepting new patients.
Frequently Asked Questions about Dr. Regan M. Duffy
How do I make an appointment with Dr. Regan M. Duffy?
You can book an appointment with Dr. Regan M. Duffy by calling their office at 503-216-6300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Regan M. Duffy a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Regan M. Duffy is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Regan M. Duffy specialize in?
While Dr. Regan M. Duffy is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Regan M. Duffy accept my insurance?
Dr. Regan M. Duffy accepts most major insurance plans, including Aetna and Cambia Health Solutions. We recommend calling the office directly at 503-216-6300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Duffy isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Duffy isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Duffy isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Duffy isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Duffy isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Dr. Duffy isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adult Soft Tissue SarcomaDr. Duffy isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaDr. Duffy isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Duffy isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Brain Stem CancerDr. Duffy isExperienced. Learn about Brain Stem Cancer.